Falsely Accused? Insufficient Evidence to Conclude that Sitagliptin is a Cause of Chronic Cough

Lung. 2020 Apr;198(2):271-273. doi: 10.1007/s00408-020-00329-2.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Cough / diagnosis
  • Cough / epidemiology
  • Cough / etiology
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Dipeptidyl-Peptidase IV Inhibitors / administration & dosage
  • Dipeptidyl-Peptidase IV Inhibitors / adverse effects
  • Drug-Related Side Effects and Adverse Reactions* / diagnosis
  • Drug-Related Side Effects and Adverse Reactions* / epidemiology
  • Humans
  • Nasopharyngitis / chemically induced
  • Nasopharyngitis / diagnosis
  • Nasopharyngitis / epidemiology
  • Observer Variation
  • Risk Assessment
  • Sitagliptin Phosphate* / administration & dosage
  • Sitagliptin Phosphate* / adverse effects

Substances

  • Dipeptidyl-Peptidase IV Inhibitors
  • Sitagliptin Phosphate